Menu
Back to Journals » Drug Design, Development and Therapy » Volume 9
Original Research
Could the FDA-approved anti-HIV PR inhibitors be promising anticancer agents? An answer from enhanced docking approach and molecular dynamics analyses
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 18,145 | Dovepress* | 17,525+ | 1,083 | 18,608 | |
| PubMed Central* | 620 | 204 | 824 | ||
| Totals | 18,145 | 1,287 | 19,432 | ||
|
*Since 13 November 2015 +Since July 2016 |
|||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 12 | 0 | 0 | 0 | 3 | 9 |
View citations on PubMed Central and Google Scholar